After decades of research, gene therapy is starting to work. Shannon Boye is a professor of cellular and molecular therapeutics at the University of Florida. She is also the co-founder and chief scientific officer of Atsena Therapeutics. Shannon’s problem is this: How do you use gene therapy to…
After the treatment, one patient saw her first star. Another saw snowflakes for the first time. Other patients were newly able to navigate outside of the home or to read the labels on their child’s Halloween candy.
The company was created by ocular gene therapy pioneers Dr. Shannon Boye and Associate Scientist Sanford Boye, who also run the Shannon E. Boye Laboratory in the UF College of Medicine’s Department of Pediatrics. The lab creates technology aimed at restoring retinal function and visually-guided behavior, as well as preserving retinal structure…
In this week’s Tech Tuesday, we meet Dr. Shannon Boye, a researcher at the University of Florida, who is working to use gene therapy to restore or improve vision for people with genetic disorders causing poor eyesight or even blindness.
Using a type of “genetic scissors,” University of Florida Health researchers have successfully removed and replaced a malfunctioning gene that gradually damages photoreceptors in the eye. Working in mouse models, the researchers say the findings are a crucial step in developing a treatment for the disorder known as cone-rod dystrophy…
Two people who have been blind since childhood are having their vision restored with a gene therapy developed by University of Florida Health scientists and their collaborators, early-stage clinical trial results and recently published findings show.
Dr. Shannon Boye joins Beacon Story Podcast for the Community Storytelling show in partnership with the Foundation Fighting Blindness.
Congratulations to Dr. Kaitlyn Calabro for her receipt of the competitive NIH Pediatric Loan Repayment Program award! Kait’s award will relieve the stress of paying back student loans while she conducts her postdoctoral studies to develop a gene therapy for MYO7A- associated Usher syndrome (USH1B). The NIH Loan Repayment Programs…
Shannon Boye, a scientist at the University of Florida, is the co-founder of a new gene-therapy startup in Durham called Atsena Therapeutics. The company is making a therapy for a disease called LCA that causes blindness.
Participants of Virtual VISIONS 2020 are invited to join live for the opening presentation, “Mission Possible! What’s Next for Gene Therapy?” presented by Dr. Shannon Boye,…
